Coya Therapeutics, Inc. (COYA)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-12) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-16) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-12) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | 8-K (2025-03-18) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-06) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-12) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-19) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-08) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-08) · 99.1 | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Condensed Unaudited Interim Statements of Operations | — |
|
| Statements of Operations | — |
|
| Condensed Unaudited Interim Statements of Stockholders' Equity | — |
|
| Condensed Unaudited Interim Statements of Stockholders' Equity (deficit) | — |
|
| Statements of Stockholders' Equity | — |
|
| Statements of Stockholders' Equity (deficit) | — |
|
| Condensed Unaudited Interim Statements of Stockholders' Equity (deficit) (P) | — |
|
| Statements of Stockholders' Equity (deficit) (P) | — |
|
| Statements of Stockholders' Equity (P) | — |
|
| Condensed Unaudited Interim Statements of Cash Flows | — |
|
| Statements of Cash Flows | — |
|
| Notes | ||
| Accrued Expenses | ||
| Basis of Presentation and Significant Accounting Policies | ||
| Commitments and Contingencies | — |
|
| Commitments and Contingencies, Including License and Sponsored Research Agreements | ||
| Convertible Promissory Notes, Convertible Preferred Stock and Stockholders' Equity (deficit) | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Drl Development Agreement | ||
| Fair Value Measurements | ||
| Fixed Assets, Net | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Organization and Description of Business | ||
| Pay Vs Performance Disclosure | ||
| Prepaids and Other Current Assets | ||
| Related Party Disclosures | — |
|
| Stock-based Compensation | ||
| Stockholders' Equity | ||
| Stockholders' Equity (deficit) | — |
|
| Subsequent Events | ||